[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100440051":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":24,"centralContacts":28,"locations":36,"responsibleParty":51,"collaborators":54,"id":58,"slug":10,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":63,"eligibilityCriteria":64,"healthyVolunteers":59,"sex":65,"minAge":66,"maxAge":10,"enrollmentInfo":67,"targetDuration":10,"studyType":70,"phases":10,"briefSummary":71,"conditions":72,"keywords":74,"overallStatus":38,"whyStopped":10,"lastUpdateSubmitDate":76,"lastUpdatePostDateStruct":77,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":85},{"fullName":5,"class":6},"Massachusetts General Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Use of advanced neurotechnologies to detect consciousness and predict recovery",null,"Treating clinicians, family members (caregivers) and patients recovering from a diagnosis of coma, vegetative state, or minimally conscious state minus (i.e. minimally conscious state without language function)",[13,14],"Other: Clinician Questionnaire","Other: Semi Structured Interviews",[16,20],{"type":6,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"Clinician Questionnaire","Surveys will serve to identify preferences, expectations and concerns among clinicians and researchers surrounding data-sharing of uncertain diagnostic data generated through investigative neurotechnologies which will then be systematically evaluated.",[9],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"Semi Structured Interviews","Semi-structured interviews will further serve to identify preferences, expectations and concerns among patients, surrogates, clinicians and researchers surrounding data-sharing of uncertain diagnostic data generated through these investigative neurotechnologies which will then be systematically evaluated.",[9],[25],{"name":26,"affiliation":5,"role":27},"Michael Young, MD","PRINCIPAL_INVESTIGATOR",[29,33],{"name":26,"role":30,"phone":31,"phoneExt":10,"email":32},"CONTACT","617-724-6352","Michael.Young@MGH.HARVARD.EDU",{"name":34,"role":30,"phone":31,"phoneExt":10,"email":35},"Brian Edlow, MD","bedlow@mgh.harvard.edu",[37],{"facility":5,"status":38,"city":39,"state":40,"zip":41,"country":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"RECRUITING","Boston","Massachusetts","02114","United States",{"type":44,"coordinates":45},"Point",[46,47],-71.05977,42.35843,{"lat":47,"lon":46},[50],{"name":26,"role":30,"phone":10,"phoneExt":10,"email":32},{"type":27,"investigatorFullName":52,"investigatorTitle":53,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Michael J. Young, M.D., M.Phil","Principal Investigator",[55],{"name":56,"class":57},"National Institute of Mental Health (NIMH)","NIH","100440051",false,"NCT05010265","An Ethical Approach to Detecting Covert Consciousness","An Ethical Approach to Detecting Covert Consciousness: Data-Driven Neuroethics for Consciousness Detection (DECODE)","DECODE","Inclusion Criteria:\n\n* Patients with prior or ongoing participation as subject in a research study using neurotechnologies for diagnosis and prognosis of disorders of consciousness (DoC) at Mass General Brigham\n* Patients capable of understanding and answering questions in English\n* Patients cble to provide informed consent\n* Patients for whom MRI \u002F EEG are administered for clinical detection of consciousness and\u002For neuroprognostication\n* Family member or surrogate caregiver of patients who previously participated or are currently participating in a research study using neurotechnologies for diagnosis and prognosis of DoC at Mass General Brigham.\n* Family Members \u002F Surrogates capable of understanding and answering questions in English\n* Family Members \u002F Surrogates able to provide informed consent\n* Family member or surrogate caregiver of patients for whom MRI \u002F EEG are administered for clinical detection of consciousness and\u002For neuroprognostication\n* Research Investigators involved with research responsibilities in designing or testing neurotechnologies on patients with DoC.\n* Clinicians with clinical responsibilities caring for patients in behaviorally unresponsive state, defined as coma, vegetative state (VS), and low-level minimally conscious state (MCS).\n* Selected leaders and advisors (Community and Thought Leaders) from brain injury associations and advocacy organizations, and policy-makers involved in decision-making impacting patients with DoC.\n\nExclusion Criteria:\n\nNone","ALL","18 Years",{"count":68,"type":69},70,"ESTIMATED","OBSERVATIONAL","This study aims to develop an ethical approach to developing and deploying novel neurotechnologies to aid in the detection of consciousness and prediction of recovery after brain injury.",[73],"Disorder of Consciousness",[75],"Disorders of consciousness, Advanced neuroimaging","2025-09-05",{"date":78,"type":79},"2025-09-11","ACTUAL",{"date":81,"type":79},"2022-02-01",{"date":83,"type":69},"2027-07",{"name":5,"class":6},1]